04 June 2022 : Clinical Research
Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November 15 and December 10, 2021 Using a Single Lateral Flow Test, the Panbio™ COVID-19 Ag Rapid Test
Mariusz Gujski1ABCDEG, Paulina Mularczyk-Tomczewska1BCDEF*, Filip Raciborski2ABCDE, Piotr Samel-Kowalik2ABCDE, Łukasz Samoliński
3ADE, Dorota Olczak-Kowalczyk4ABDE, Mateusz Jankowski 5ABCDEF
DOI: 10.12659/MSM.936962
Med Sci Monit 2022; 28:e936962
Table 4 Detailed characteristics of the participants with the positive Panbio™ COVID-19 Ag Rapid Test.
| Field of the study | Group ID code | Age (years) | Gender | Vaccinated | COVID-19 vaccine (first dose) | Number of vaccine doses | Date of last vaccine dose | COVID-19 in the past |
|---|---|---|---|---|---|---|---|---|
| Medicine | L5-20- | 23 | Male | Yes | Pfizer | 3 | Oct 2021 | No |
| Medicine | L5-12- | 23 | Female | Yes | Pfizer | 3 | Oct 2021 | No |
| Medicine | L5-19- | 23 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
| Dentistry | D3-01- | 20 | Female | Yes | AstraZeneca | 2 | May 2021 | No |
| Dentistry | D3-N1- | 21 | Female | Yes | AstraZeneca | 2 | May 2021 | Yes |
| Dentistry | D3-N1- | 22 | Male | Yes | Pfizer | 2 | Feb 2021 | No |
| Dentistry | D3-N1- | 21 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
| Dentistry | D3-N1- | 22 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
| Nursing | I3-08A- | 22 | Female | No | – | – | – | No |
| Nursing | I3-08A- | 21 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
| Nursing | I3-03B- | 22 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
| Nursing | I3-03B- | 20 | Female | Yes | Pfizer | 2 | Feb 2021 | No |
| Nursing | I3-03B- | 21 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
| Nursing | I3-03A- | 21 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |
| Dietetics | B5-P1- | 23 | Female | Yes | AstraZeneca | 2 | Jun 2021 | No |